Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
301130.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.15B
Close$
$-5.33
119.5% downside
Current Fair Value
119.5% downsideOvervalued by 119.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.15 Billion |
|---|---|
| Enterprise Value | $2.08 Billion |
| Dividend Yield | $0.14 (0.52%) |
| Earnings per Share | $0.29 |
| Beta | 0.52 |
| Outstanding Shares | 75,494,685 |
Return
| Return on Equity | 0.68% |
|---|---|
| Return on Assets | 0.55% |
| Return on Invested Capital | -0.04% |
Valuation & Multiples
| P/E Ratio | 367.1 |
|---|---|
| PEG | -361.51 |
| Price to Sales | 13.65 |
| Price to Book Ratio | 2.48 |
| Enterprise Value to Revenue | 10 |
| Enterprise Value to EBIT | -6027.13 |
| Enterprise Value to Net Income | 353 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
313 employees
CEO: Jun Zhang Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd specializes in the comprehensive process of pharmaceutical goods, encompassing their research, development, production, and distribution. Its portfolio features therapeuti...